25G-NBOMe

A synthetic psychedelic compound

25G-NBOMe
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

25G-NBOMe is a synthetic psychedelic compound that belongs to the NBOMe series. It is a derivative of the phenethylamine 2C-G and is known for its potent hallucinogenic effects.

Chemical structure and properties

25G-NBOMe is chemically related to the 2C family of psychedelic phenethylamines. It is specifically a derivative of 2C-G, with the addition of a 2-methoxybenzyl group to the nitrogen atom, which is characteristic of the NBOMe series. This modification significantly increases the compound's affinity for the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects.

Pharmacology

The primary mechanism of action for 25G-NBOMe is its agonistic activity at the 5-HT2A receptor, a subtype of the serotonin receptor. This receptor is known to play a crucial role in the modulation of mood, perception, and cognition, which are all affected during psychedelic experiences. The compound's high potency is attributed to its strong binding affinity to this receptor.

Effects

The effects of 25G-NBOMe are similar to those of other psychedelics, such as LSD and psilocybin. Users report intense visual hallucinations, altered perception of time and space, and profound changes in thought processes. The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the experience lasting anywhere from 6 to 12 hours.

Risks and safety

25G-NBOMe, like other NBOMe compounds, has been associated with a number of adverse effects, particularly at higher doses. These can include vasoconstriction, tachycardia, hypertension, and hyperthermia. There have been reports of severe toxicity and fatalities associated with the use of NBOMe compounds, often due to their high potency and the difficulty in accurately dosing them.

Legal status

The legal status of 25G-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound in their region.

Related pages

• NBOMe series
• 2C family
• Psychedelic drug
• Serotonin receptor